Cite
HARVARD Citation
Huizinga, T. et al. (n.d.). THU0114 Effect of Anti-Cyclic Citrullinated Peptide 2 Immunoglobulin M Serostatus on Efficacy Outcomes Following Treatment with Abatacept Plus Methotrexate in the Avert Trial. Annals of the rheumatic diseases. pp. 234-235. [Online].